Focus and Scope
Pharma Deals Review is a journal that delivers relevant analyses on deals within the pharmaceutical and biotechnology industry worldwide. It examines industry issues and their impact on the deal making environment.
The Journal analyses specific deals and reports on trends and developments within deal-making in different technology and therapy areas. It also publishes articles based on the analyses of data presented in PharmaDeals v4 Agreements database, as well as many other sources of information available to our expert team of writers.
Pharma Deals Review is read by professionals in the life sciences industry involved in business development, licensing, finance, law, marketing, and by healthcare professionals working in deal making. The journal is also of interest to researchers in academic institutions and business schools, to lawyers and investment analysts, as well as to media professionals.
Section Policies
CompiledPDFs
Open Submissions |
Indexed |
Peer Reviewed |
Research & Development
Open Submissions |
Indexed |
Peer Reviewed |
Licensing
Open Submissions |
Indexed |
Peer Reviewed |
Mergers & Acquisitions
Open Submissions |
Indexed |
Peer Reviewed |
Joint Venture
Open Submissions |
Indexed |
Peer Reviewed |
Business Commentaries
Open Submissions |
Indexed |
Peer Reviewed |
Distribution & Marketing
Open Submissions |
Indexed |
Peer Reviewed |
Cartoons
Open Submissions |
Indexed |
Peer Reviewed |
Deal Trackers
Open Submissions |
Indexed |
Peer Reviewed |
Features
Open Submissions |
Indexed |
Peer Reviewed |
General
Open Submissions |
Indexed |
Peer Reviewed |
Company Profile
Open Submissions |
Indexed |
Peer Reviewed |
Royalties
Open Submissions |
Indexed |
Peer Reviewed |
Editorial
Open Submissions |
Indexed |
Peer Reviewed |
Conference Report
Open Submissions |
Indexed |
Peer Reviewed |
Technology Access
Open Submissions |
Indexed |
Peer Reviewed |
Opinion & Analysis
Open Submissions |
Indexed |
Peer Reviewed |
Pharma Deals Review
Pharma Deals Review is a rapid communications publication that delivers instant, relevant articles and analyses on deal making. It examines industry issues and examines their impact on the deal making environment.
Pharma Deals Review is read by professionals in the life sciences industry involved in business development, licensing, finance, law, marketing, and by healthcare professionals working in deal making. The journal is also of interest to researchers in academic institutions and business schools as well as to media professionals.